PHASE I CLINICAL TRIAL ASSESSING THE MEK INHIBITOR SELUMETINIB (AZD6244; ARRY-142886) WITH CONCOMITANT THORACIC RADIOTHERAPY (RT) IN PATIENTS WITH STAGE III-IV NON SMALL CELL LUNG CANCER (NSCLC)
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
MEK inhibitor,thoracic radiotherapy,Phase I trial,Non small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要